Neglected Tropical Diseases Diagnosis Market to grow with a CAGR of 4.09% through 2030F
Increasing healthcare infrastructure and a supportive
regulatory environment are the major drivers for the Global Neglected Tropical
Diseases Diagnosis Market in the forecast period, 2026-2030F
According
to TechSci Research report, “Neglected Tropical Diseases
Diagnosis Market - Global Industry Size, Share, Trends, Competition, Opportunities and
Forecast, 2020-2030F”, Global Neglected Tropical Diseases Diagnosis Market was
valued at USD 6.20 billion in 2024 and is anticipated to witness an impressive
growth in the forecast period with a CAGR of 4.09% through 2030. This can be
due to collaborations and partnerships among leading companies with a diverse
approach to merge the expertise of individual companies and to strengthen their
position in the market.
The
impact of Neglected Tropical Diseases (NTDs) on Sustainable Development Goals
(SDGs) drives the demand for the Global Neglected Tropical Diseases Diagnosis
Market. NTDs disproportionately affect the world's poorest populations,
trapping them in a cycle of poverty. These diseases hinder economic development
by reducing productivity and increasing healthcare costs. Accurate diagnosis
and treatment of NTDs can help lift communities out of poverty, making it a
priority to address NTDs and, consequently, the need for diagnostic tools. NTDs
can lead to malnutrition, growth stunting, and reduced agricultural
productivity, directly impacting food security. Addressing NTDs through early
diagnosis and treatment can help improve nutritional outcomes, aligning with
efforts to achieve zero hunger. Good Health and Well-Being: SDG 3 directly
relates to health, and NTDs have a substantial impact on health outcomes. Early
diagnosis is essential for effective treatment and the prevention of
complications, contributing to improved health and well-being. Quality
Education: NTDs often lead to school absenteeism and cognitive impairments,
hindering access to quality education. By controlling and eliminating NTDs,
students can attend school regularly, driving the demand for early diagnosis
and treatment. NTDs can disproportionately affect women and girls, leading
to gender disparities in health and education. Early diagnosis and treatment
can mitigate these gender inequalities and promote gender equality. Many
NTDs thrive in environments with poor sanitation and limited access to clean
water. Improved sanitation and hygiene practices, along with early diagnosis,
are crucial for NTDs control.
Variability in disease distribution is a challenge in the Global Neglected Tropical Diseases (NTDs) Diagnosis Market. This variability refers to the uneven distribution of NTDs across different regions and populations. NTDs encompass a diverse group of diseases caused by various pathogens, and their distribution varies widely. Some NTDs are highly localized, while others have a more widespread presence. This heterogeneity complicates efforts to design and deploy diagnostic tools and interventions. NTDs are often endemic in specific geographic regions. For example, diseases like Chagas disease are primarily found in Latin America, while African trypanosomiasis is prevalent in sub-Saharan Africa. The geographic variability necessitates region-specific approaches to diagnosis and control. Some NTDs, despite being localized, have the potential to cause outbreaks and epidemics when environmental conditions are favorable. This unpredictability challenges healthcare systems' preparedness and diagnostic capacities. The variability in disease distribution requires targeted resource allocation. Regions with a high burden of specific NTDs may require more diagnostic tests and interventions, which can strain limited healthcare resources. Developing and distributing diagnostic tests for NTDs with highly variable distribution can be logistically challenging. Manufacturers may prioritize diseases with larger affected populations, potentially leaving those with localized distribution underserved.
Browse
over XX market data Figures and spread through 110 Pages and an in-depth
TOC on " Global Neglected Tropical Diseases Diagnosis Market”
Global Neglected Tropical Diseases Diagnosis Market is
segmented based on Disease, Diagnostic Method, Service Type, End-Use, and by
region.
Based
on end-use, the Global Neglected Tropical Diseases Diagnosis Market largest
share was held by Clinical laboratory segment in the forecast period and is
predicted to continue expanding over the coming years. Diagnosing neglected tropical diseases often
requires specialized laboratory tests that can detect the presence of
parasites, antibodies, or specific antigens. Clinical laboratories are
well-equipped to perform these complex tests accurately. Clinical laboratories
are known for their ability to provide precise and reliable diagnostic results,
which is crucial in diagnosing NTDs correctly. Many NTDs have similar symptoms
to other diseases, so accurate diagnosis is essential. Clinical laboratories
typically employ trained professionals, including medical technologists and
pathologists, who have the expertise to handle and interpret NTD diagnostic
tests. Clinical laboratories have access to advanced diagnostic equipment and
technologies, such as molecular diagnostics and serological assays, which are
essential for detecting NTDs accurately. Proper handling and processing of
patient samples are critical for NTD diagnosis. Clinical laboratories have
established protocols for handling various types of biological specimens.’
Based
on region, Asia-pacific region witnesses the fastest growth in the
Global Neglected Tropical Diseases Diagnosis Market. The
Asia-Pacific region is home to a significant proportion of the global NTDs
burden. Countries in this region are affected by a range of NTDs, including
lymphatic filariasis, schistosomiasis, soil-transmitted helminthiasis, and
others. The prevalence of these diseases drives the demand for diagnostic
tools. The Asia-Pacific region has a vast and densely populated demographic.
The sheer number of people at risk of NTDs translates into a substantial market
for diagnostic tests and services. Many countries in the Asia-Pacific region
have experienced significant economic growth and development in recent years.
This growth has led to increased investments in healthcare infrastructure,
including diagnostic capabilities. Rapid urbanization in the region has led to
improved healthcare access in urban areas, increasing the demand for diagnostic
services. However, rural areas may still face challenges in access to
healthcare. Several governments in the Asia-Pacific region have recognized the
importance of addressing NTDs and have implemented NTD control and elimination
programs. These programs often include efforts to strengthen diagnostic
capacities.
Some of the major companies operating in the Global
Neglected Tropical Diseases Diagnosis Market include:
·
F. Hoffmann-La Roche Ltd
·
Abbott Laboratories Inc.
·
Thermo Fisher Scientific Inc.
·
ZeptoMetrix
·
InBios International, Inc.
·
DiaSys Diagnostics Systems GmbH
·
Genome Diagnostics Pvt. Ltd.
·
Omega Diagnostics Group Plc
·
Oscar Medicare Pvt Ltd.
·
Coris BioConcept
Download Free Sample Report
Customers can also request 10% free customization on this
report.
“North
America is expected to drive significant demand for Neglected Tropical Diseases
(NTDs) diagnosis due to increasing awareness, advanced healthcare
infrastructure, and growing research initiatives. The presence of established
diagnostic companies investing in innovative technologies further accelerates
market growth. Enhanced government support, rising funding for disease
surveillance, and improved access to diagnostic tools contribute to early
detection and better disease management. The collaborations between healthcare
organizations and research institutions are fostering advancements in
diagnostic accuracy and accessibility. These factors collectively support the
substantial growth of the Global NTDs Diagnosis Market, ensuring improved
health outcomes and effective disease control strategies" said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based Global
management consulting firm.
Neglected Tropical Diseases Diagnosis Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease (Dengue, Chikungunya, Rabies, Buruli Ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Dracunculiasis, others), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type (Centralized Service, POC Service), By End Use (Clinical Labs, Hospital/Clinics, Home Healthcare), By Region & Competition, 2020-2030F", evaluated the future growth
potential of Global Neglected Tropical Diseases Diagnosis Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Neglected Tropical Diseases Diagnosis
Market.
Contact
TechSci Research LLC
420
Lexington Avenue
Suite
300, New York
United
States- 10170
M:
+13322586602
Email: sales@techsciresearch.com
Web:
https://www.techsciresearch.com